A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer (Q74597412)
Jump to navigation
Jump to search
scientific article published on 01 August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer |
scientific article published on 01 August 2002 |
Statements
A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer (English)
Anthony W Tolcher
Leonard Reyno
Peter M Venner
Scott D Ernst
Malcolm Moore
Richard S Geary
Kim Chi
Sean Hall
Wendy Walsh
Andrew Dorr
Elizabeth Eisenhauer
1 August 2002